Čulić, O., Cordero, M. D., Žanić Grubišić, T., Somborac Bačura, A., Batičić Pučar, L., Detel, D. ... Barišić, K. (2016). Serum activities of adenosine deaminase,
dipeptidyl peptidase IV and prolyl endopeptidase
in patients with fibromyalgia: diagnostic
implications. Clinical rheumatology, 35. (10), 2565-2571. doi: 10.1007/s10067-016-3377-8
Čulić, Ognjen, et al. "Serum activities of adenosine deaminase,
dipeptidyl peptidase IV and prolyl endopeptidase
in patients with fibromyalgia: diagnostic
implications." Clinical rheumatology, vol. 35, no. 10, 2016, pp. 2565-2571. https://doi.org/10.1007/s10067-016-3377-8
Čulić, Ognjen, Mario D. Cordero, Tihana Žanić Grubišić, Anita Somborac Bačura, Lara Batičić Pučar, Dijana Detel, Jadranka Varljen and Karmela Barišić. "Serum activities of adenosine deaminase,
dipeptidyl peptidase IV and prolyl endopeptidase
in patients with fibromyalgia: diagnostic
implications." Clinical rheumatology 35, no. 10 (2016): 2565-2571. https://doi.org/10.1007/s10067-016-3377-8
Čulić, O., et al. (2016) 'Serum activities of adenosine deaminase,
dipeptidyl peptidase IV and prolyl endopeptidase
in patients with fibromyalgia: diagnostic
implications', Clinical rheumatology, 35(10), pp. 2565-2571. doi: 10.1007/s10067-016-3377-8
Čulić O, Cordero MD, Žanić Grubišić T, Somborac Bačura A, Batičić Pučar L, Detel D, and sur.. Serum activities of adenosine deaminase,
dipeptidyl peptidase IV and prolyl endopeptidase
in patients with fibromyalgia: diagnostic
implications. Clinical rheumatology [Internet]. 2016 [cited 2025 January 15];35(10):2565-2571. doi: 10.1007/s10067-016-3377-8
O. Čulić, et al., "Serum activities of adenosine deaminase,
dipeptidyl peptidase IV and prolyl endopeptidase
in patients with fibromyalgia: diagnostic
implications", Clinical rheumatology, vol. 35, no. 10, pp. 2565-2571, 2016. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:184:388913. [Accessed: 15 January 2025]